Obsessive-compulsive Disorder
📧 Sign up to get email alerts when something new happens for Obsessive-compulsive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Pharmacogenetics in Primary Care Psychotropics [Phase 3]
Phase 3 clinical trial update on pharmacogenetics in primary care psychotropics sponsored by the University of Arizona, studying major depre…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Deep-brain Stimulation in Obsessive-compulsive Disorder: Randomized, Double-blinded Clinical Trial [NA]
A randomized, double-blind study evaluating deep-brain stimulation for obsessive-compulsive disorder has completed.
-
CLINICAL_TRIALS withdrawal · 2017-07-11Clinical Trial Update: Analysis of Visual-Motor Task Electrophysiological Activity During Deep Brain Stimulation for Treatment-Resistant Movement Disorders
A clinical trial evaluating deep brain stimulation for treatment-resistant movement disorders, with Obsessive-Compulsive Disorder listed as …
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Characterization of Childhood-Onset Obsessive-Compulsive Disorder
A completed clinical trial conducted by the National Institute of Mental Health characterizing childhood-onset obsessive-compulsive disorder…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Serotonin Transporters in Obsessive-Compulsive-Related Disorders
A completed NIMH-sponsored clinical trial investigated the role of serotonin transporters in obsessive-compulsive-related disorders, includi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions
This document provides an update on a completed NIMH clinical trial evaluating obsessive-compulsive disorder and related conditions, includi…
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: The Efficacy of TBCT Compared to ERP in the Treatment of OCD Patients, by the Assessment of Magnetic Resonance. [NA]
Completed clinical trial evaluating TBCT versus ERP for obsessive-compulsive disorder, using MRI assessments.
-
FDA approval · 2017-06-15FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
FDA approved a supplemental application for ZOLOFT (sertraline hydrochloride) submitted by ROERIG, indicating an approved modification to th…
-
CLINICAL_TRIALS research · 2017-06-01Clinical Trial Update: Psycho-education Intervention for Postpartum OCD and it's Influence on Symptom Severity and Treatment Self Referral Rates [NA]
This clinical trial update discusses a psycho-education intervention for postpartum obsessive-compulsive disorder and its impact on symptom …
-
FDA approval · 2017-05-24FDA Approved: CLOMIPRAMINE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for clomipramine hydrochloride submitted by SpecGx LLC.
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder [Phase 2]
A Phase 2 trial evaluating intranasal ketamine for obsessive-compulsive disorder was terminated; results were posted in May 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Memantine Augmentation in Treatment-Resistant Adults With Obsessive-Compulsive Disorder [Phase 2]
Phase 2 trial evaluating memantine augmentation in treatment-resistant adults with obsessive-compulsive disorder; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder [Phase 2]
An open-label Phase 2 trial of Rapastinel (formerly GLYX-13) in obsessive-compulsive disorder has completed and results have been posted.
-
CLINICAL_TRIALS research · 2017-05-08Clinical Trial Update: tDCS as an add-on Treatment in SSRI-resistant OCD [NA]
A clinical trial update evaluating transcranial direct current stimulation as an add-on to SSRIs for obsessive-compulsive disorder that is r…
-
FDA approval · 2017-04-28FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
The FDA has approved a supplemental application for paroxetine filed by Padagis US LLC. This notice indicates FDA approval of an amendment t…
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: Cognitive Behavioural Therapy for Children With Autism Spectrum Disorder and Obsessive Compulsive Behaviour [NA]
A completed clinical trial evaluating Cognitive Behavioural Therapy for children with autism spectrum disorder and obsessive-compulsive diso…
-
FDA approval · 2017-04-05FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals Limited's original application for fluoxetine hydrochloride (fluoxetine) as a generic drug.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD [NA]
A clinical trial comparing dextro-amphetamine and caffeine for treatment-resistant obsessive-compulsive disorder has completed, with results…
-
FDA approval · 2017-03-24FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
The FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company. The action updates th…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Memantine Augmentation in Obsessive-Compulsive Disorder [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating memantine augmentation in obsessive-compulsive disorder, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD) [Phase 4]
Phase 4 clinical trial update for duloxetine in obsessive-compulsive disorder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Deep Brain Stimulation for Severe Obsessive Compulsive Disorder [NA]
The clinical trial evaluating deep brain stimulation for severe obsessive-compulsive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: 2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD [NA]
A completed clinical trial investigated whether adding D-Cycloserine to cognitive-behavioral therapy improves outcomes in pediatric obsessiv…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD [Phase 2]
Phase 2 randomized trial comparing intranasal ketamine with intranasal midazolam in individuals with obsessive-compulsive disorder; the stud…
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels
A completed clinical trial update assessing whether phases of the menstrual cycle influence blood levels of lithium and sertraline in indivi…